Price, J. G., Shantzer, L., Jacobs, C. D., Singh, A., Mara, A., Niedzwiecki, D., … Torok, J. A. J. (2020). Radiation Therapy and Immune Checkpoint Inhibition in Metastatic Non-Small Cell Lung Cancer: Determining Toxicity and Efficacy of Combination Treatment. In INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (Vol. 108, pp. E149–E150).

Price, J. G., L. Shantzer, C. D. Jacobs, A. Singh, A. Mara, D. Niedzwiecki, J. Clarke, C. R. Kelsey, J. K. Salama, and JA Jr Torok. “Radiation Therapy and Immune Checkpoint Inhibition in Metastatic Non-Small Cell Lung Cancer: Determining Toxicity and Efficacy of Combination Treatment.” In INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 108:E149–50, 2020.

Price JG, Shantzer L, Jacobs CD, Singh A, Mara A, Niedzwiecki D, et al. Radiation Therapy and Immune Checkpoint Inhibition in Metastatic Non-Small Cell Lung Cancer: Determining Toxicity and Efficacy of Combination Treatment. In: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2020. p. E149–50.

Price, J. G., et al. “Radiation Therapy and Immune Checkpoint Inhibition in Metastatic Non-Small Cell Lung Cancer: Determining Toxicity and Efficacy of Combination Treatment.” INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, vol. 108, no. 3, 2020, pp. E149–50.

Price JG, Shantzer L, Jacobs CD, Singh A, Mara A, Niedzwiecki D, Clarke J, Kelsey CR, Salama JK, Torok JAJ. Radiation Therapy and Immune Checkpoint Inhibition in Metastatic Non-Small Cell Lung Cancer: Determining Toxicity and Efficacy of Combination Treatment. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2020. p. E149–E150.